Replies to post #219754 on Biotech Values

[DewDiligence]

RVNC—For each new indication, will the FDA continue to require the long term safety trial?

No. The rationale for a separate safety study to support the CD indication is that the CD dose is as much as 10x higher than the dose for glabellar lines.